DEM PHARMACEUTICALS LIMITED is a limited company established in London, UK, operating under Reg. 15081460. Founded in 2023, the company specializes in the acquisition, processing, and distribution of high-quality pharmaceutical goods, primarily focusing on specialized pharmaceutical products. DEM PHARMACEUTICALS is classified as a ltd company, indicating a smaller, privately owned structure. The company’s core business revolves around providing access to and facilitating the use of NASA’s digital elevation models (DEMs), derived from airborne and space-based data. These DEMs are crucial for detailed terrain analysis, particularly for mapping and understanding Earth’s surface features. The company’s primary service is to offer access to and support for this data, supporting research and development across various pharmaceutical sectors. DEM PHARMACEUTICALS is actively involved in the international pharmaceutical market, demonstrating a commitment to global collaboration. The company’s workforce comprises skilled individuals with a focus on pharmaceutical product management and data analysis. As a Skilled Worker visa holder, DEM PHARMACEUTICALS is rated as a Worker (A rating), signifying a high level of competency and experience within the company. The company’s international presence is a key element of its strategy, allowing for collaboration and distribution across various regions. The company’s key focus is on providing reliable and accessible data for scientific and industrial applications.

DEM PHARMACEUTICALS LIMITED is a limited company established in London, UK, operating under Reg. 15081460. Founded in 2023, the company specializes in the acquisition, processing, and distribution of high-quality pharmaceutical goods, primarily focusing on specialized pharmaceutical products. DEM PHARMACEUTICALS is classified as a ltd company, indicating a smaller, privately owned structure. The company’s core business revolves around providing access to and facilitating the use of NASA’s digital elevation models (DEMs), derived from airborne and space-based data. These DEMs are crucial for detailed terrain analysis, particularly for mapping and understanding Earth’s surface features. The company’s primary service is to offer access to and support for this data, supporting research and development across various pharmaceutical sectors. DEM PHARMACEUTICALS is actively involved in the international pharmaceutical market, demonstrating a commitment to global collaboration. The company’s workforce comprises skilled individuals with a focus on pharmaceutical product management and data analysis. As a Skilled Worker visa holder, DEM PHARMACEUTICALS is rated as a Worker (A rating), signifying a high level of competency and experience within the company. The company’s international presence is a key element of its strategy, allowing for collaboration and distribution across various regions. The company’s key focus is on providing reliable and accessible data for scientific and industrial applications.